AI-generated summary
The authors report a randomized, evaluator-blinded trial of 40 participants with melasma who received either a picosecond alexandrite laser or a combined Q-switched and long-pulse Nd:YAG laser approach. Both groups showed significant reductions in MASI scores, and the combined Nd:YAG approach produced greater improvement. Safety was similar overall, though pain scores were significantly higher in the picosecond group.
- Participants
- 40
- Who or what was studied
- Participants with melasma and Fitzpatrick Skin Types III and IV
- Limits stated in the abstract
- The abstract describes a single trial of 40 participants with an evaluator-blinded design, and it does not describe a long-term follow-up beyond 24 weeks.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.